MOBP Activators
MOBP activators encompass a range of chemical compounds that can either directly enhance the functional activity of MOBP or indirectly trigger signaling events leading to its activation. These compounds operate primarily via the RhoA/ROCK pathway, a signaling cascade that MOBP is known to interact with. The RhoA/ROCK pathway is involved in various cellular processes such as cell migration, proliferation, and differentiation. The alteration of this pathway through various means can lead to the functional activation of MOBP.
Calmodulin and Ionomycin enhance the functional activity of MOBP by increasing intracellular calcium levels, which in turn can activate the RhoA/ROCK pathway. Forskolin and Rolipram also enhance the functional activity of MOBP by increasing the levels of cAMP, a second messenger that can activate the RhoA/ROCK pathway. Additionally, Phorbol 12-Myristate 13-Acetate (PMA) and Staurosporine, potent activators of Protein Kinase C (PKC), can also enhance the functional activity of MOBP by activating this pathway. Inhibitors of specific proteins in the RhoA/ROCK pathway, such as Y-27632 and Fasudil (ROCK inhibitors), H-89 (a PKA inhibitor), U0126 (a MEK1/2 inhibitor), and Blebbistatin (a non-muscle myosin II inhibitor), can also indirectly enhance the functional activity of MOBP through the disinhibition of this pathway. Furthermore, Okadaic acid enhances the functional activity of MOBP by inhibiting protein phosphatases 1 and 2A, thereby enhancing the phosphorylation state of proteins in the RhoA/ROCK pathway.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $300.00 | ||
Calmodulin is a calcium-binding protein that plays a crucial role in calcium signaling. Calcium signaling can activate the RhoA/ROCK pathway, which MOBP is known to interact with. By binding to calcium, calmodulin can facilitate the activation of this pathway, leading to an enhanced functional activity of MOBP. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, which increases the levels of cyclic AMP (cAMP). cAMP is a second messenger that can activate the RhoA/ROCK pathway. As a result, Forskolin can indirectly enhance the functional activity of MOBP. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC can activate the RhoA/ROCK pathway, which MOBP is known to influence. Therefore, PMA can indirectly enhance the functional activity of MOBP. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. As calcium is a key activator of the RhoA/ROCK pathway, ionomycin can indirectly enhance the functional activity of MOBP. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a specific inhibitor of phosphodiesterase 4 (PDE4), which results in an increase in cAMP levels. By increasing cAMP levels, rolipram can activate the RhoA/ROCK pathway and indirectly enhance the functional activity of MOBP. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK, a key component of the RhoA/ROCK pathway. By inhibiting ROCK, Y-27632 can indirectly enhance the functional activity of MOBP through the disinhibition of this pathway. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, okadaic acid can enhance the phosphorylation state of proteins in the RhoA/ROCK pathway, indirectly enhancing the functional activity of MOBP. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC. By inhibiting PKC, staurosporine can indirectly enhance the activity of the RhoA/ROCK pathway and, therefore, the functional activity of MOBP. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil is a potent inhibitor of ROCK, a key component of the RhoA/ROCK pathway. By inhibiting ROCK, Fasudil can indirectly enhance the functional activity of MOBP through the disinhibition of this pathway. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin is a specific inhibitor of non-muscle myosin II, which is a downstream effector of the RhoA/ROCK pathway. Thus, blebbistatin can indirectly enhance the functional activity of MOBP by altering the downstream effects of this pathway. | ||||||